Trials / Completed
CompletedNCT01532297
Application of Citrate Dialysate in Chronic Haemodialysis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Fresenius Medical Care Deutschland GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study investigating the safety and efficacy of the citrate dialysis solution compared to standard acetate dialysis solution. Use of citrate dialysis solution is not associated with a clinically relevant development of adverse events. It is hypothesized that citrate dialysate may provide a local anticoagulation effect in the dialyser improving removal of uremic toxins.
Detailed description
It is hypothesized that citrate dialysate may provide a local anticoagulation effect in the dialyser improving removal of uremic toxins. Study investigating the safety and efficacy of the citrate dialysis solution compared to standard acetate dialysis solution. Use of citrate dialysis solution is not associated with a clinically relevant development of adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Citrate dialysate (CiDi) | Use during chronic dialysis 3x/week |
| DEVICE | Standard dialysate (StDi) | Use during chronic dialysis 3x/week |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2013-04-01
- Completion
- 2013-08-01
- First posted
- 2012-02-14
- Last updated
- 2014-06-06
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01532297. Inclusion in this directory is not an endorsement.